Among the estimated 235 million people worldwide who have asthma,1 a sizable portion are unable to achieve adequate disease control without high doses of inhaled corticosteroids (ICS) and/or oral corticosteroids, or are generally unresponsive to these therapies. These individuals, comprising approximately 5% to 10% of the total asthma population,2 are considered to have severe asthma.…
Ultimately, epinephrine should not be withheld for the treatment of anaphylaxis in patients with long QT syndrome, although certain precautions should be heeded.
Bronchitis symptoms, considered a defining characteristic of chronic obstructive pulmonary disease (COPD), are not fully reversible with available treatments. COPD also encompasses lung emphysema, another condition currently considered to be progressive.1 Results of recent preclinical trials published in Annals of the American Thoracic Society suggest that the use of inducible nitric oxide synthase (iNOS) and…
Patients with asthma have demonstrated an elevated risk for depression and anxiety that is potentially twice as high as that in the general population.
Further patient advocacy is needed to ensure that recipients of HCV-infected organs have access to direct-acting antivirals as early as possible, including in a prophylactic manner, if data continue to support its benefit.
